Shruti Rakesh Tiwari, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 44035 Riverside Pkwy Ste 300, Leesburg, VA 20176 Phone: 703-208-3155 Fax: 703-724-7503 |
David Jaeyoon Lee, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 44045 Riverside Pkwy, Leesburg, VA 20176 Phone: 703-858-6000 Fax: 703-858-6900 |
Dr. Mei-hwa Rose Firestone, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 450, Leesburg, VA 20176 Phone: 703-656-9805 Fax: 703-729-6576 |
Dr. Syed Salman Ali, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 450, Leesburg, VA 20176 Phone: 703-656-9805 Fax: 703-729-6576 |
Amitabha Sarma, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 44035 Riverside Pkwy Ste 300, Leesburg, VA 20176 Phone: 703-208-3155 Fax: 703-724-7503 |
News Archive
A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.
A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.
Professor Suzanne Cory, the former director of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, has been named the recipient of the 2009 Pearl Meister Greengard Prize.
Merge Healthcare (NASDAQ: MRGE), a health IT solutions provider, today announced its settlement with the SEC of the multi-year investigation into the conduct of two former company executives, and the circumstances which led to a restatement in 2006 of the company's 2002 through 2005 financial statements. This investigation ran concurrent with two shareholder lawsuits, which were resolved in 2008.
› Verified 7 days ago